eCite Digital Repository
Idarubicin, cytarabine in standard or high-dose, and etoposide ± lenograstim (G-CSF). Combinations giving high remission rates in acute myeloid leukaemia.
Citation
Lowenthal, RM and Bradstock, KM and Matthews, JP and Enno, A and Gill, D and Page, FJ and Rooney, KF and Taylor, KM, Idarubicin, cytarabine in standard or high-dose, and etoposide lenograstim (G-CSF). Combinations giving high remission rates in acute myeloid leukaemia., VIII Congress Asian Pacific Division International Society of Haematology, October, Brisbane, Australia, pp. 162. (1995) [Conference Extract]
Item Details
| Item Type: | Conference Extract |
|---|---|
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Oncology and carcinogenesis |
| Research Field: | Oncology and carcinogenesis not elsewhere classified |
| Objective Division: | Health |
| Objective Group: | Other health |
| Objective Field: | Other health not elsewhere classified |
| UTAS Author: | Lowenthal, RM (Professor Ray Lowenthal) |
| UTAS Author: | Rooney, KF (Associate Professor Kim Rooney) |
| ID Code: | 5073 |
| Year Published: | 1995 |
| Deposited By: | Clinical Sciences |
| Deposited On: | 1995-08-01 |
| Last Modified: | 1996-02-01 |
| Downloads: | 0 |
Repository Staff Only: item control page